Phosphate binders include calcium acetate or carbonate, sevelamer hydrochloride or
carbonate, magnesium and lanthanum carbonate, and aluminum carbonate or hydroxide …

Calcium acetate, an effective phosphorus binder in patients with renal failure. Calcium salts
are increasingly used as phosphorus binders in patients with chronic renal failure. Calcium …

An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with
chronic kidney disease. Chronic kidney disease has the potential to induce sequelae that …

Hyperphosphatemia is an inevitable consequence of end-stage chronic kidney disease and
is present in the majority of dialysis patients. Hyperphosphatemia is observationally and …

Control of serum phosphorus (PO 4) has been long recognized as a goal in the nutritional
and medical management of the patients with chronic kidney disease. Phosphate-binding …

The first reported double-blind cross-over comparison between the phosphorus binders
calcium carbonate and calcium acetate was undertaken in 15 stable patients on chronic …

The ideal serum level of phosphate in patients on dialysis, and the benefits of controlling
levels of phosphate in serum remain unclear despite observational studies that associate …

Medicare costs for phosphate binders for US dialysis patients and patients with chronic
kidney disease enrolled in Medicare Part D exceeded $1.5 billion in 2015. Previous data …

OBJECTIVE: This study was designed to evaluate the efficacy of magnesium carbonate as a
phosphate binder in hemodialysis patients. DESIGN: This study was a prospective …

Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study.
The use of calcium carbonate (CaCO 3) to bind phosphorus (P) in chronic hemodialysis …